Product Insights This sector includes Ozempic, Trulicity, Mounjaro, Xultophy, Victoza, Saxenda, and Others
The largest meta-analysis to date, comprising 13 cardiovascular outcome trials involving 83,258 patients with and without diabetes, confirmed that GLP-1 Ras significantly reduced major adverse cardiovascular events (MACEs), all-cause mortality, cardiovascular mortality, fatal and non-fatal strokes, coronary revascularization, and composite kidney outcomes [87]
A Were seeing the greatest impact on the missing middle the mid-volume combination products and emerging biologics that still require robust, regulated device manufacturing
Its recognised international non-proprietary name is emideltide
Patel S, Khan H, Majumdar A
Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline